Medeloop is an AI-driven medical research platform based in Menlo Park, California. Led by CEO Rene Caissie, it automates the entire research cycle—from grant discovery to data analysis—by transforming medical data into a graph database to deliver deep insights and fast results. Its suite includes a grant platform for identifying and applying for funding, a dual-component studies platform (mobile app for participants and web app for researchers), a no-code analytics platform, and a manuscript publication platform. These integrated tools are designed to let researchers manage every aspect of a study from inception to publication. Medeloop partners with healthcare institutions worldwide. The company intends to use the new funds to expand operations and accelerate development efforts. Medeloop offers an AI-driven platform that integrates, harmonizes, and analyzes health data using advanced AI tools to support clinical research. The product streamlines researcher discovery and simplifies grant applications, data collection and harmonization, biomarker and trend identification, and manuscript submissions. Medeloop says these insights have the potential to expedite the clinical research process. The company plans to use the funds to launch an end-to-end solution for early-stage clinical research. Leadership includes CEO Dr. Rene Caissie, CTO Raghav Samavedem, CSO Dr. Josh Walonoski, and COO Andy Yakulis. Medeloop is based in Palo Alto, CA.

Total raised

$24M

Funding rounds

2

Latest round

Series A

Latest activity

Nov 2024